Latest News and Press Releases
Want to stay updated on the latest news?
-
Not for distribution to U.S. newswire services or for release publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States. Any failure to...
-
Completed End-of-Phase 2 meeting with the FDA; Company expects to provide a regulatory update in early 2Q 2026 and remains on track to initiate a Phase 3 study in chronic tetraplegia in mid-2026....
-
VANCOUVER, British Columbia , March 31, 2026 (GLOBE NEWSWIRE) -- Rio Silver Inc. (the "Company" or "Rio Silver") (TSX.V: RYO) (OTC: RYOOF) is pleased to announce that it has closed its non-brokered...
-
MISSISSAUGA, Ontario, March 31, 2026 (GLOBE NEWSWIRE) -- Next Hydrogen Solutions Inc. (“Next Hydrogen”) (TSXV:NXH), a leading Canadian designer and manufacturer of hydrogen electrolyzers, reports...
-
JERSEY CITY, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX) (“SCYNEXIS” or the “Company”), a biotechnology company focused on developing innovative new therapies to address...
-
MONTREAL, March 30, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or “the Company”) (TSX:PYR) (OTCQX:PYRGF) (FRA:8PY1), a leader in ultra-high temperature processes & engineering...
-
AIRJ Achieves 2025 Objectives Across Technology Validation, Product Development, and Strategic Partnerships RONAN, Mont., March 30, 2026 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation...
-
New York, NY, March 30, 2026 (GLOBE NEWSWIRE) -- Future Money Acquisition Corporation (NASDAQ: FMACU) (the “Company”) today announced the closing of its initial public offering of 11,200,000 units...
-
Company prepares to file Investigational Device Exemption (IDE) for Novel CBGM Technology, targeting US Clinical Trial Launch in Second Half of 2026 US Patent and Trademark Office (USPTO) issued...
-
SOLANA BEACH, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) today announced the closing of its previously announced private placement of 3,188,407 shares of...